SCHEMBL31748359

SCHEMBL31748359

C[Si](C)(C)CCOCn1cc(C#N)c2nc(NC3Cc4ccc(C5(O)CCC5)cc4C3)c(F)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31748684 0.85 — —
SCHEMBL31748315 0.85 JAK2 (0.31) —
SCHEMBL31748579 0.83 SYK (0.30) —
SCHEMBL31748640 0.82 DGAT1 (0.33) —
SCHEMBL31748473 0.81 — —
SCHEMBL31748697 0.74 GABRA5 (0.34) —
SCHEMBL31748621 0.70 SYK (0.30) —
SCHEMBL31748668 0.69 DGAT1 (0.33) —
SCHEMBL31748374 0.68 EGFR (0.31) —
SCHEMBL31748550 0.66 DGAT1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388571-A1 AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF BIOLEXIS THERAPEUTICS INC (US) 2025-12-25 — — US disclosed
Send feedback